Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

The First Affiliated Hospital of Henan University of Science and Technology clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with The First Affiliated Hospital of Henan University of Science and Technology as lead sponsor. Synced 19 Nov 2026
6Current trials
3Recruiting now
5Drugs in these trials
1Trial register
At a glance

The First Affiliated Hospital of Henan University of Science and Technology is the lead sponsor of 6 current clinical trials in our China register. 3 are recruiting patients now. The most common phase is Phase 2. The drugs named most often in its trials are Albumin-Bound Paclitaxel /nab-Paclitaxel, Camrelizumab and Capecitabine. The most-studied condition is Esophageal Cancer.

ClinicalTrials.gov trials by status

  • Recruiting350%
  • Not yet open117%
  • Active, closed117%
  • By invitation117%

Trials by phase

  • Phase 2233%
  • Not applicable233%
  • Early Phase 1117%
  • Observational117%
01

Clinical trials sponsored by The First Affiliated Hospital of Henan University of Science and Technology

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
NCT07347080 · ClinicalTrials.gov ↗ · T2DM
Early Phase 1 Recruiting 2026-01 China
Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT07622797 · ClinicalTrials.gov ↗ · Late-stage Resectable Esophageal Squamous Carcinoma
Phase 2 Recruiting 2025-11 China
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
NCT02972372 · ClinicalTrials.gov ↗ · Esophagus Cancer
Not applicable Recruiting 2016-11 China
Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07829952 · ClinicalTrials.gov ↗ · Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 Not yet open 2026-11 China
Large-scale Models of Esophageal Cancer and Related Research
NCT07642401 · ClinicalTrials.gov ↗ · Esophageal Cancer
Observational By invitation 2026-05 China
Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD Surgery
NCT06722300 · ClinicalTrials.gov ↗ · Esophageal Cancer
Not applicable Active, closed 2024-05 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in The First Affiliated Hospital of Henan University of Science and Technology trials

5 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in The First Affiliated Hospital of Henan University of Science and Technology trials

6 conditions
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China63

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Esophageal Cancer

SponsorTrials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences7
Zhejiang University5
Fujian Medical University Union Hospital3
Erasmus Medical Center3
Lantheus Medical Imaging1
Qurient1
Lumicell1
Energenx Medical1
Fifth Affiliated Hospital, Sun Yat-Sen University1
Zhao Jun1

Sponsors with the most current trials registered for this condition.

06

Questions about The First Affiliated Hospital of Henan University of Science and Technology trials

How many clinical trials does The First Affiliated Hospital of Henan University of Science and Technology sponsor?

The First Affiliated Hospital of Henan University of Science and Technology is the lead sponsor of 6 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 19 November 2026. Completed and withdrawn studies are not counted.

Are The First Affiliated Hospital of Henan University of Science and Technology trials recruiting?

Yes. 3 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is The First Affiliated Hospital of Henan University of Science and Technology testing?

Its current trials name 5 drugs and biologicals as interventions. The most frequent are Albumin-Bound Paclitaxel /nab-Paclitaxel (1), Camrelizumab (1), Capecitabine (1), Carboplatin (1) and Ipilimumab (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.